Search research articles
Contact Us
Filters
Showing results (141-150 of 246) with videos related to
Page
of 25
Sort By:
The Oncologist
|
March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis
Jad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
Clinical Chemistry and Laboratory Medicine
|
October 11, 2007
Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy
Peter Lembessis, Pavlos Msaouel, Antonis Halapas, et al.
International Journal of Cancer
|
March 19, 2021
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience
Omar Alhalabi, Elshad Hasanov, Nathaniel R Wilson, et al.
The Journal of Urology
|
September 9, 2022
Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study
Mary E Westerman, Kelly K Bree, Pavlos Msaouel, et al.
JAMA Network Open
|
February 3, 2021
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults
Casey Lee McAtee, Joseph Lubega, Kristen Underbrink, et al.
BJUI Compass
|
October 17, 2024
MR-Linac-guided stereotactic radiotherapy for CT-indiscernible intravascular renal cell carcinoma tumours
Mihir D Shanker, Zhiqian Henry Yu, Jinzhong Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2026
Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management
Simone Krebs, Ahmed E Salem, Nghi C Nguyen, et al.
Heart, Lung & Circulation
|
February 13, 2016
Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection Fraction
Mohammad Khalid Mojadidi, Jose Nahun Galeas, David Goodman-Meza, et al.
European Urology Open Science
|
July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
Wei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
Breast Cancer Research and Treatment
|
November 7, 2009
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model
Ianko D Iankov, Pavlos Msaouel, Cory Allen, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 246) with videos related to
Sort By:
Page
of 25
The Oncologist
|
March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis
Jad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
Clinical Chemistry and Laboratory Medicine
|
October 11, 2007
Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy
Peter Lembessis, Pavlos Msaouel, Antonis Halapas, et al.
International Journal of Cancer
|
March 19, 2021
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience
Omar Alhalabi, Elshad Hasanov, Nathaniel R Wilson, et al.
The Journal of Urology
|
September 9, 2022
Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study
Mary E Westerman, Kelly K Bree, Pavlos Msaouel, et al.
JAMA Network Open
|
February 3, 2021
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults
Casey Lee McAtee, Joseph Lubega, Kristen Underbrink, et al.
BJUI Compass
|
October 17, 2024
MR-Linac-guided stereotactic radiotherapy for CT-indiscernible intravascular renal cell carcinoma tumours
Mihir D Shanker, Zhiqian Henry Yu, Jinzhong Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2026
Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management
Simone Krebs, Ahmed E Salem, Nghi C Nguyen, et al.
Heart, Lung & Circulation
|
February 13, 2016
Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection Fraction
Mohammad Khalid Mojadidi, Jose Nahun Galeas, David Goodman-Meza, et al.
European Urology Open Science
|
July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
Wei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
Breast Cancer Research and Treatment
|
November 7, 2009
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model
Ianko D Iankov, Pavlos Msaouel, Cory Allen, et al.
Page
of 25